Please wait while the formulary information is being retrieved.
METHOCARBAMOL (METHOCARBAMOL)
- Muscle spasm
750 mg tablet
- 1 tablet (750 mg) by oral route 3 times per day
500 mg tablet
- 2 tablets (1,000 mg) by oral route 4 times per day
750 mg tablet
- 1 tablet (750 mg) by oral route 3 times per day
Muscle spasm
- 2 tablets (1,000 mg) by oral route 4 times per day
- 2 tablets (1,500 mg) by oral route 3 times per day
- 3 tablets (1,500 mg) by oral route 4 times per day for 2 days
- 3 tablets (1,500 mg) by oral route 4 times per day for 3 days
- 2 tablets (1,500 mg) by oral route 4 times per day for 3 days
- 2 tablets (1,500 mg) by oral route 4 times per day for 2 days
- 1 tablet (750 mg) by oral route 3 times per day
- 1 tablet (750 mg) by oral route 4 times per day
- 1 tablet (750 mg) by oral route every 4 hours
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- Disease of liver
- Kidney disease with reduction in GFR
METHOCARBAMOL (METHOCARBAMOL)
- Muscle spasm
- Injection site sequelae
- Visual changes
- Blurred vision
- Diplopia
- Dizziness
- Drowsy
More Frequent
Severe
Less Severe
- Allergic dermatitis
- Bradycardia
- Conjunctivitis
- Drug fever
- Nasal congestion
- Pruritus of skin
- Skin rash
- Urticaria
- Dyspepsia
- Flushing
- Headache disorder
- Muscle weakness
- Nausea
- Nystagmus
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute confusion
- Anaphylaxis
- Dyskinesia
- Hypotension
- Jaundice
- Leukopenia
- Obstructive hyperbilirubinemia
- Syncope
- Thrombophlebitis
- Tonic clonic seizure
Less Severe
- Insomnia
- Memory impairment
- Sedation
- Vertigo
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Methocarbamol (oral)
Safety and efficacy not established in children age less than 12 years.
- 1 Day – 12 Years
- Safety and efficacy not established in children age less than 12 years.
Methocarbamol
- Severity Level:
C
- Additional Notes:
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Methocarbamol
Insufficient human data available
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
Methocarbamol (oral)
Neuro/Psych-May cause lightheadedness, sedation, worsen cognitive impairment and increase fall risk. Cardiovascular- Risk of hypotension and syncope.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | N | N | Y | Y | N | N |
BEERS: Y HEDIS: Y STOPP: N
No Known Risk
None
- None
Muscle spasm | |
M62.83 | Muscle spasm |
M62.830 | Muscle spasm of back |
M62.831 | Muscle spasm of calf |
M62.838 | Other muscle spasm |
R25.2 | Cramp and spasm |
0-9 | A-Z |
---|---|
M62.83 | Muscle spasm |
M62.830 | Muscle spasm of back |
M62.831 | Muscle spasm of calf |
M62.838 | Other muscle spasm |
R25.2 | Cramp and spasm |
Formulary Reference Tool